Skip to main content

Aducanumab Treatment for Alzheimer’s is Getting a Second Chance

After 16 long years without any truly viable treatment options for Alzheimer’s, there is some optimism on the horizon in a stunning reversal on the formerly-rejected antibody therapy, aducanumab. The newest research reveals that large quantities of the medication do, in fact, decrease cognitive decline at the beginning stages of Alzheimer’s.

According to Rebecca Edelmayer, director of scientific engagement at the Alzheimer’s Association, “It could be a game-changer for the field. It could be one of the first disease-modifying therapies approved for Alzheimer’s disease.”

Biogen, the maker of aducanumab, reports significant benefits for dementia patients in a number of areas: activities of daily living, memory, language, and orientation. Biogen introduced its intentions to pursue regulatory approval in the U.S., with a long range aim of launching the medication internationally.

With an expected request for approval by the FDA as quickly as early 2020, the drug is slated to possibly become the first treatment method to actually reduce the clinical decline of Alzheimer’s. Additionally, it should open doors to many other treatment options that impact amyloid beta plaques, connecting other trials that target the immune system, inflammation, blood vessels, and synaptic cell health. Searching for the most beneficial management of the disease is a challenging endeavor, and it is likely that a variety of these approaches are likely to be necessary, according to Edelmayer.

The next challenge? Persuading the FDA to approve the treatment after earlier failed trials. If approved, aducanumab will first be provided to those who had signed up for earlier trials, and hopefully, soon offered to others dealing with all the challenges of Alzheimer’s as well.

For the approximate six million senior Americans battling Alzheimer’s (a number expected to more than double during the next three decades), plus the family who take care of them, these latest findings could be life-changing, as there are presently only minimally effective symptom-management medications available. As we await a treatment, the team at Heaven at Home Senior Care is ready to assist dementia patients with highly skilled, trained, and qualified caregivers who make the most of creative therapeutic approaches that focus on each person’s distinct strengths and ensure each individual is living to the fullest possible potential.

Families have options for in-home care in Dallas and surrounding areas that can help with Alzheimer’s care. To learn more about highly effective Alzheimer’s care that will help boost quality of life within the comfort of home, contact the dementia care experts at Heaven at Home Senior Care at 866-381-0500 and request an in-home assessment or additional information.

The post Aducanumab Treatment for Alzheimer’s is Getting a Second Chance appeared first on Heaven at Home Care.



from Heaven at Home Care https://ift.tt/2EAGGnP
via IFTTT
Labels:

Comments

Post a Comment

Popular posts from this blog

Sleep in the Elderly: What is Normal?

If you are a caregiver for a senior, or even just have elderly people in your life, you may wonder about their sleeping habits. It sometimes seems that the elderly don’t need as much sleep as the average person. You may feel like the elderly in your life are sleeping a lot, or sleeping too much during the day. Unfortunately when it comes to sleep in the elderly, what is normal may not necessarily be what is healthy. Excessive sleep or daytime sleeping in the elderly are all related to sleep disorders and can be helped. How Many Hours of Sleep Does an Elderly Person Need? A pervading myth related to sleep claims that elderly adults need less sleep than the average adult. It’s not quite clear how this myth began. Perhaps because elderly adults tend to nap in the afternoons and sleep less during the night. Perhaps because the elderly tend to wake up earlier in the morning, it appears they do not need to sleep as much. Whatever the reason, it remains a myth. From the mid-’20s onward, do...
1 comment
Read more

Dads and Pops: Your Good Health Matters to Us 

Did you know  June is  Men’s Health Month  and Father’s Day anchors Men’s Health Week ?   Celebrate dad on Father’s Day and thank him for all he  has  done, but  also  make sure to seize an opportunity sometime this month to have a conversation with him about his health. This awareness campaign has the critical purpose of informing men   that avoiding preventive healthcare puts them at real and serious risk of  contracting a disease or  acquiring  a chronic condition.   Studies consistently  show the numbers go against men , particularly as they advance into their senior years.   Even with dramatic advances in diagnosis and treatment over the past 100 years, men’s life expectancy still lags significantly behind women. According to  Harvard Health ,  the gap is widening. In 1900, the life expectancy for women was 48.3 years vs. 46.3 for men. In 2017, it was 81.1 years for women vs. 76.1 for men. Harvard...
Post a Comment
Read more

Film Screening at Samvedna Senior Care

On 30th September, 2019, Samvedna Senior Care Foundation hosted the 2nd film festival of generations in association with Heidelberg University, Germany. The film Sputnik Moment – 30 years and beyond was screened at our senior citizen centre in Gurgaon for our members and staff. The film highlighted how senior citizens in Germany and the US were taking up second careers to fill their time, engage meaningfully and also get support through additional income. Post the screening Dr. Martin Gieselmann, Executive Secretary, SAI, Heidelberg University and Dr. Constanze, Coordinator DAAD Project, Heidelberg University along with our team engaged with the audience in an interesting discussion on the Indian scenario. Members shared that in India it is not easy for senior citizens to pick up jobs after retirement, however it was interesting to see that many in the audience did have jobs post retirement. They also spoke about stereotypes and social attitudes towards ageing and shared their per...
Post a Comment
Read more